Factors associated with recurrence in patients with curatively resected stage I–II lung cancer
- 31 August 2011
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 73 (2) , 222-229
- https://doi.org/10.1016/j.lungcan.2010.11.013
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trialThe Lancet Oncology, 2006
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Current surgical treatment of nonsmall cell lung cancer 2001European Respiratory Journal, 2002
- Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trialRadiotherapy and Oncology, 2002
- A study of postoperative radiotherapy in patients with non–small-cell lung cancer: a randomized trialInternational Journal of Radiation Oncology*Biology*Physics, 2000
- A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinomaCancer, 1999
- The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 diseaseBritish Journal of Cancer, 1996
- Incidence of local recurrence and second primary tumors in resected stage I lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.Journal of Clinical Oncology, 1984
- Site of Recurrence in Patients with Stages I and II Carcinoma of the Lung Resected for CureThe Annals of Thoracic Surgery, 1981